field test (OF, Day +
13) and the elevated plus maze test (EPM, Day +
13), as well as the body weight
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Iakupova, Ellina M.,
Fakhretdinova, Albina A.,
Gilmanshin, Timur R.,
Panda-Jonas, Songhomitra,
Jonas, Jost B. (2025) . Prevalence of any, early, intermediate and late AMD was 439/932 (47.1%; 95%CI:44.0,50.0), 126/932 (
13.5%; 95
as a potential treatment for FTD. Finally, a review of the current scientific literature identified
13